Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (RABAMES)
Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
The primary objective of this pilot study is to compare the functional and anatomic outcomes
of chronic macular edema secondary to branch retinal vein occlusion (BRVO) treated with argon
laser photocoagulation versus intravitreal ranibizumab (Lucentis®) injection versus a
combination of both.
Phase:
N/A
Details
Lead Sponsor:
Klinikum Ludwigshafen
Collaborators:
Coordination center for clinical studies, Mainz, Germany Norvartis Pharma, Nuremberg, Germany